Stereotactic body radiation therapy for inoperable lung cancer

JAMA

Volumn 303, Issue 23, 2010, Pages 2354-2355

  Rusthoven, Kyle E ^a   Pugh, Thomas J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LETTER; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MICROMETASTASIS; MINIMALLY INVASIVE SURGERY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; STEREOTACTIC BODY RADIATION THERAPY; TH1 CELL; TH2 CELL; THORACOTOMY; TREATMENT OUTCOME; WHOLE BODY RADIATION; CANCER STAGING; LUNG TUMOR; METHODOLOGY; NOTE; RADIATION EXPOSURE; RADIOSURGERY; T LYMPHOCYTE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNITY, CELLULAR; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOSURGERY; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 77953624534     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.777     Document Type: Letter

References (5)

1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076.
2. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928-935.
3. Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009; 114(3):589-595.
4. Ito N, Nakamura H, Tanaka Y, Ohgi S. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer. 1999;85(11):2359-2367. (Pubitemid 29244844)
5. Whitson BA, D'Cunha J, Andrade RS, et al. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity. Ann Thorac Surg. 2008;86(6):1735-1744.